Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

News & Views

News & Views ATLA 31, 549–550, 2003 549 will be open to interpretation. Thus, although points Update on the EU Chemicals Policy 1 and 2, respectively, refer to an increase in the use of QSARs and alternative in vitro tests, it is not clear The final draft of the European Commission’s new how this will be promoted and (more importantly) chemicals legislation (Registration, Evaluation and additionally funded within the European Union Authorisation of Chemicals, or REACH) was pub- 1 (EU). Point 3 will presumably result in a reduction lished in six volumes in October 2003. The over- in the numbers of animals used in relation to the riding goal of the new legislation is the protection numbers of tests performed. However, the number of of human health and the environment, with tests may include ones that are unnecessary. Lastly, another key aim being the “promotion of non-ani- in relation to the reference to GLP in point 5, the reg- mal testing”. Following a public consultation exercise during ulations indicate that several sets of otherwise reli- able and documented data from animal tests not the summer of 2003, the Commission received more than 6400 submissions. Comments on the performed under GLP, or derived http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Alternatives to Laboratory Animals SAGE

News & Views

Alternatives to Laboratory Animals , Volume 31 (6): 2 – Nov 1, 2003
Download PDF
5 pages

Loading next page...
 
/lp/sage/news-views-ErUhjUBZMT

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
SAGE
Copyright
© 2003 Fund for the Replacement of Animals in Medical Experiments
ISSN
0261-1929
eISSN
2632-3559
DOI
10.1177/026119290303100602
Publisher site
See Article on Publisher Site

Abstract

ATLA 31, 549–550, 2003 549 will be open to interpretation. Thus, although points Update on the EU Chemicals Policy 1 and 2, respectively, refer to an increase in the use of QSARs and alternative in vitro tests, it is not clear The final draft of the European Commission’s new how this will be promoted and (more importantly) chemicals legislation (Registration, Evaluation and additionally funded within the European Union Authorisation of Chemicals, or REACH) was pub- 1 (EU). Point 3 will presumably result in a reduction lished in six volumes in October 2003. The over- in the numbers of animals used in relation to the riding goal of the new legislation is the protection numbers of tests performed. However, the number of of human health and the environment, with tests may include ones that are unnecessary. Lastly, another key aim being the “promotion of non-ani- in relation to the reference to GLP in point 5, the reg- mal testing”. Following a public consultation exercise during ulations indicate that several sets of otherwise reli- able and documented data from animal tests not the summer of 2003, the Commission received more than 6400 submissions. Comments on the performed under GLP, or derived

Journal

Alternatives to Laboratory Animals – SAGE

Published: Nov 1, 2003

There are no references for this article.